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Objectives:The healing response to vascular injury is characterized by neointimal thickening. Proliferation and phenotypic
transformation of vascular smooth muscle cells (SMCs) have been implicated in this process. We sought to investigate the
role of survivin, a dual regulator of cell proliferation and apoptosis, in lesion formation after diverse forms of vascular
injury.
Methods: Rabbits underwent either carotid interposition vein grafting (n  17) or bilateral femoral balloon injury (BI; n
 29); some in the BI group were placed on a high-cholesterol diet. A subset of BI arteries were treated with local
adenoviral gene delivery of a survivin dominant negative-mutant (AdT34A) versus vector or saline controls. Survivin
expression in vessels was analyzed by quantitative reverse transcriptase polymerase chain reaction (RT-PCR) and by
immunohistochemistry (IHC), which also included markers of SMC differentiation. Specimens of human tissue
including failed lower extremity bypass grafts and carotid plaque were also examined.
Results: RT-PCR and IHC demonstrated increased survivin expression in all experimental models, colocalizing at early
times with proliferating and -actin-expressing cells but was largely absent in mature, contractile SMCs. Delivery of
AdT34A after BI attenuated neointimal hyperplasia.
Conclusion:These studies provide strong evidence supporting a role for survivin in the cellular response to vascular injury.
(J Vasc Surg 2005;41:682-90.)
Clinical Relevance: The regulation of cell proliferation, death, and phenotype after vascular interventions remains
incompletely understood. We investigated the role of the inhibitor of apoptosis protein survivin in diverse models of
vascular injury. The results suggest that survivin is an important modulator of the generalized vascular injury response
and may represent a relevant target for therapies targeting intimal hyperplasia.The cellular response to vascular injury involves a
complex interplay between resident cells of the vessel
wall such as endothelial cells (ECs), smooth muscle cells
(SMCs), and adventitial fibroblasts, and circulating ele-
ments such as inflammatory cells or progenitor (“stem”)
cells that are recruited to participate in the healing
response. Regardless of the mode of vascular injury—
lipid accumulation (atherogenesis), mechanical stretch
(balloon angioplasty), or vein arterialization (surgical
bypass)—a common paradigm of neointimal thickening
ensues in which cells expressing a proliferative, proin-
flammatory, and less-differentiated phenotype contrast
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682dramatically with the normal constituents of uninjured
vessels.
Activation of resident SMCs in the vessel wall, with
subsequent migration, proliferation, and transformation
from a contractile to synthetic state, has been one of the
long-standing paradigms of the vascular injury response.
More recently, it has become apparent that other popula-
tions of cells may be involved in this process, including
circulating progenitor cells1,2 and adventitial “myofibro-
blasts”.3,4
Under conditions of injury, vascular SMCs switch from
a contractile phenotype with slow replication into a migra-
tory cell with a high proliferation rate, reversing the process
of ontogenetic development.5,6 Ultimately, as lesions ma-
ture at sites of vascular injury, a progressive restoration of
SMC differentiation is observed,7 with a gradual return of
the contractile phenotype. The regulation of this process of
dedifferentiation and redifferentiation is poorly under-
stood.
Increased total cellularity is a common feature of the
injury response, thus appropriately focusing attention on
the balance between cell proliferation and cell death. Ap-
optosis is a critical feature of vessel-wall remodeling at all
stages, from vascular development and injury to chronic
vascular lesions.8 Survivin also known as Birc5, was first
identified as a member of the inhibitor of apoptosis gene
family9 and subsequently has been demonstrated to have a
unique, dual role in the regulation of cell proliferation and
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tubules during mitosis at the G2/M phase10,11 and is
thought to block apoptosis by direct interference with
caspase-9 activation.
Although largely absent in normal adult tissues, sur-
vivin is expressed in embryonic tissues12 and in virtually all
forms of human cancer examined to date, and its expression
has been linked to poor prognosis.13,14 Survivin expression
is upregulated at the mitotic phase of the cell cycle, and its
activity requires phosphorylation by the mitotic kinase
p34cdc2-cyclin B1 at a unique site (threonine residue 34).15
Dominant-negative (nonphosphorylatable) survivin con-
structs have demonstrated antineoplastic activity, generat-
ing considerable interest in survivin targeting for cancer
therapy.16
From this unique function at the interface of cell pro-
liferation and cell death, a potential role for survivin in the
regulation of vascular injury has recently been postulated.
Survivin has been shown to mediate vascular endothelial
growth factor-induced EC survival, which is critical to
angiogenesis and re-endothelialization.17 In recent stud-
ies,18 we demonstrated that survivinmediates the antiapop-
totic effects of platelet derived growth factor in SMCs and
identified survivin expression in experimental neointima
formation. The objectives of the current investigations
were to examine the role of survivin more broadly in
vascular injury, including clinically relevant models of ath-
erosclerosis and vascular intervention, and to determine its
transcriptional activity and cellular localization in develop-
ing lesions. The results strongly suggest that survivin is an
important modulator of the generalized injury response in
the vessel wall and a potential unique marker of dedifferen-
tiated cells that are involved in the formation of neointima.
METHODS
Animal care. New ZealandWhite rabbits (3 to 3.5 kg;
N  46) were used in these studies (Fig 1). Animal exper-
imentation was carried out in accordance with theGuide for
the Care and Use of Laboratory Animals (Institute of Lab-
oratory Animal Resources, Commission on life Sciences,
National Research Council, Washington, DC. National
Academy Press, 1996), under a protocol approved by the
Harvard Medical Area Standing Committee on Animals.
The rabbits were fed normal chow (Purina high-fiber
rabbit diet) (PharmaServ Inc, Framingham, Mass) or a
high-cholesterol diet (Purina rabbit chow plus 5% [w/w]
hydrogenated coconut oil, 0.5% [w/w] added cholesterol)
(Research Diets, New Brunswick, NJ) ad libitum.
Animals were anesthetized for surgical procedures with
ketamine (25 mg/kg) and xylazine (5 mg/kg) by intra-
muscular injection, followed by intermittent intravenous
dosing of a ketamine (2.5 mg/kg) and xylazine (0.5 mg/
kg) mixture. In procedures involving the use of viral vec-
tors, the rabbits were placed in quarantine for the initial 24
hours postoperatively. Postoperative analgesia was main-
tained by the daily intramuscular administration of Flunix-
amine (5 mg) for at least 48 hours.Balloon injury model. A longitudinal incision along
the medial aspect of the hindlimb was used to bilaterally
expose the common femoral arteries in 29 animals (9 on
cholesterol diet, 20 on normal chow). A 2F Fogarty bal-
loon angioplasty catheter (Baxter Healthcare Corp, Deer-
field, Ill) was introduced through the proximal superficial
femoral artery, advanced 15 cm into the abdominal aorta,
and withdrawn with an inflated balloon three times. The
superficial femoral artery was ligated, incisions were closed,
and the animals were allowed to recover until sacrifice.
Gene transfer of dominant-negative survivin
construct. A subset of 10 animals fed normal chow under-
going balloon injury also underwent local arterial gene
transfer targeting survivin. Two replication-deficient ad-
enoviruses, the phosphorylation-defective Thr34 Ala sur-
vivin mutant (Ad-T34A-GFP) or control vector Ad-GFP
were generated as described.16 Viruses were used in-vivo at
a final concentration of 110 pfu/mL in phosphate-buffered
saline.
Immediately after balloon injury, a 22-gauge catheter
was inserted in the superficial femoral artery. A vessel
segment extending from the proximal external iliac to the
common femoral arteries was isolated by tying all branches
and was rinsed with saline. Microclamps were placed at the
origin of the external iliac and profunda femoris arteries,
and the virus solution was instilled intraluminally with care
taken to avoid overdistension. After 30 minutes, the solu-
tion was aspirated, the cannula was removed, and flow was
restored to the distal hindlimb via a patent profunda fem-
oris artery. In eight animals, treatment was paired directly
with AdT34A on one side and the control vector (AdGFP)
on the contralateral artery. In two animals, both injured
arteries were treated with normal saline to create a second
control group not exposed to any viral vector.
Four animals were sacrificed at 4 days for analysis of
proliferation and apoptosis by immunohistochemistry and
six animals at 28 days (four vessels in each of the three
treatment groups) for morphometric analysis.
Jugular vein carotid interposition graft model. We
used the anastomotic cuff technique as previously de-
scribed19 for the creation of a carotid interposition vein
graft (n  17). In brief, a paramedian neck incision was
used to expose and harvest the right internal jugular vein.
The vein ends were passed through a polyurethane cuff (2
to 3 mm long) custom-fashioned from a 4F vascular intro-
ducer sheath (Pinnacle #15-720, Boston Scientific, Natick,
Mass), then everted over the outside of the cuffs, and
secured with an overlying 6-0 Prolene (Ethicon) ligature.
The ipsilateral carotid artery was exposed and a longitudinal
1-cm arteriotomy was made. The ends of the cuffed-vein
graft (reversed orientation) were inserted into the arterial
lumen and secured by another 6-0 Prolene ligature overly-
ing each cuff. In this model, once flow is restored, the
interposed segment of the artery is completely divided to
allow graft extension. Graft patency was confirmed by
visualizing pulsatile flow within the graft and incisions were
then closed.
histo
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duced and the patency of the studied vessels was confirmed,
an intravenous heparin bolus (1,000 U) was given, and
animals were sacrificed with an overdose of anesthetic. Vein
grafts or a segment of the balloon-injured arteries extend-
ing from the external iliac to the common femoral arteries
were harvested. A segment from themiddle of vein grafts or
the injured common femoral arteries was excised and im-
mediately snap-frozen in optimal cutting temperature com-
pound (Sakura Finetek, Inc) and stored at –80°C for later
sectioning. For RNA analysis, the remainder of the vessels
were immediately placed in ice cold RNA-Later (Ambion
Inc, Austin, Tex) and stored at –80°C. In the gene transfer
subgroup, balloon-injured arteries were perfusion-fixed
(80 mm Hg mean pressure) with 10% neutral-buffered-
formalin (NBF) (Sigma, St Louis, Mo), excised, and placed
in NBF. They were then paraffin-embedded for sectioning
and morphometry.
Quantitative morphometry. Vessels harvested from
the gene transfer group at 28 days were divided into three
blocks, and three random, evenly spaced sections from each
block were stained with hematoxylin and eosin. Paraffin-
embedded 6-m section (n 12 vessels; 108 sections)
images were collected using a microscope (Olympus BX41)
and an online digital camera (Kodak Co, Rochester, NY).
The circumference of the lumen, internal elastic lamina
(IEL), and external elastic lamina (EEL) were outlined by
using image-analysis software (Scion Software, Frederick,
Md), and the areas within each perimeter were calculated.
Fig 1. Schematic drawing of the animal experiments d
were divided into two groups, normal chow or choleste
carotid interposition vein graft as shown. IHC, ImmunoThe neointimal area (NI  IEL area – lumen area), themedial area (MEEL area – IEL area), and theNI/M area
ratio were calculated. Mean values from the nine measured
sections were assigned to each treated artery.
Human tissues. Human tissue was obtained under
protocols approved by the institutional review board of the
Brigham and Women’s Hospital. Carotid plaques (n  3)
obtained from surgical endarterectomy, failed lower-
extremity vein bypass grafts (84 to 1,330 days old; n  8),
normal greater saphenous veins (n  2), and radial arteries
(n 2) were examined for survivin expression as described
later.
Immunohistochemistry. Cryosections (6 m thick)
of uninjured arteries (n  10), injured arteries (n  28),
vein grafts (n 12), and normal jugular veins (n 3) were
thawed at room temperature and fixed in ice-cold acetone
(Sigma) for 10 minutes at 4°C, endogenous peroxidase
quenched in 1.5%H202 solution for 10minutes, blocked in
10% horse serum, and incubated with antibodies to survivin
(60.1, NOVUS, 1:500 or 0.004 g/Ll), Ki-67 (MIB-1,
1:100) (Cell Marque Corp., Hot Springs, Ark), Smooth-
elin (MAB3242, 1:200) (Chemicon, Temecula, Calif),
Desmin (DE-R-11 1:100) (Novocastra , United King-
dom), and SMC -Actin HHF-35 (Enzo Life Science,
Farmingdale, NY) for 1 hour at room temperature. Bound
primary antibodies were detected using avidin-biotin-per-
oxidase (NovaRed Peroxidase Substrate Kit, Vector Labo-
ratories, Burlingame, Calif). TUNEL staining was per-
formed in paraffin sections as per manufacturer’s
recommendations (Apoptag Kit, Intergen Co, Purchase,
ed in this study. New Zealand White rabbits (NZWR)
et and underwent either balloon catheter injury (BI) or
chemistry.escrib
rol diNY). To obtain proliferative or apoptotic indices (gene
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within the media/neointima of six evenly spaced sections
per vessel were counted manually; eight high-power fields
were evaluated per section, covering at least 85% of the
vessel’s circumference to obtain an index of positive stained
cells/total number of cells.
RNA isolation and reverse transcriptase polymerase
chain reaction. Total RNA isolation was performed on
rabbit vessels (18 BI arteries; 15 uninjured arteries; 8
control veins; 13 vein grafts; 1 testicle control) using the
Trizol method (Gibco). From each vessel, 1 g of total
RNA was used in a reverse transcriptase polymerase chain
reaction (RT-PCR) to generate cDNA (BioRad iScript
cDNA Synthesis Kit). The primers for survivin were de-
signed to span an intron (exon1 to exon2; from genomic
DNA sequence ref# NT_010641) to ensure amplification
of rabbit cDNA and not genomic DNA. Quantification of
gene expression was performed by RT-PCR (BioRad iCy-
cler iQ Real-time PCR Detection System, Bio-Rad Labo-
ratories) using the Bio-Rad iQ SYBR Green Supermix,
which uses the fluorescein compound SYBR-Green for
amplicon detection (see Web version for details). All reac-
tions were performed in triplicate and each experiment was
repeated at least once to ensure consistency.
Detail of RT-PCR Methods
The survivin primers used were: forward primer (95-
119; NM_001168), 5=-GAC CAC CGC ATC TCT ACA
TTC AAG A-3=; reverse primer (233-212; NM_001168),
5=-TGA AGCAGA AGA AAC ACTGGGC-3=. Beta-actin
primers used were: forward primer, 5=- GAG ACC TTC
AAC ACC CCA GCC ATG-3=; reverse primer, 5=- AGC
CAG GTC CAG ACG CAG GAT-3=. PCR conditions
included an initial 3= denaturation step at 95 degrees and a
50-cycle amplification program (95 degrees, 30 seconds; at
60.3 degrees, 30 seconds; and 72 degrees, 30 seconds).
Reaction products were subjected to agarose (2%) gel elec-
trophoresis after each experiment to confirm the presence
of a single band of expected size for survivin (139 bp) and
-actin (171 bp). Standard curves for survivin and -actin
were generated using serial 10-fold dilutions of rabbit
testicle cDNA. Threshold cycle readings for each experi-
ment were plotted on their appropriate standard curves to
determine the starting amount of survivin and -actin
mRNA. The relative amount of survivin transcript was
divided by the relative amount of -actin transcript to
obtain a normalized measure of survivin expression.
Statistical analysis. Quantitative RT-PCR data were
compared using one-way analysis of variance (ANOVA)
and unpaired t tests. For the quantitative morphometry
aspect of the gene transfer experiments, a mixed-effects
ANOVA was used to examine the effects of treatment
assignment, accounting for intra-animal variability. A
paired t test was used to directly compare measured param-
eters between AdT34A and control vector (AdGFP)
treated arteries. Statistical significance was established at P
 0.05.RESULTS
Immunohistochemical evidence of survivin expres-
sion in diverse models of vascular injury
Survivin expression in mechanically injured arter-
ies. Uninjured arteries from animals fed normal chow dem-
onstrated an absence of staining for survivin, Ki-67 or
RAM-11 (not shown). In balloon-injured arteries (Fig 2),
survivin staining was prominent throughout all layers at 7
days after injury and overlapped with -actin within the
minimally developed neointima and the media. Of note, at
this early time point, a significant population of survivin
cells were also identified in the adventitia, and these adven-
titial cells were negative for all SMC markers. Dramatic
proliferation (Ki-67) was noted at 7 days in all layers, which
overlapped with survivin expression. By 14 days, the neo-
intima was more developed, and survivin expression was
decreased in the luminal aspect of the neointima, although
still prominent in the deep neointima, media, and adventi-
tia. At 35 days, survivin expression persisted in defined areas
of the deep neointima, inner media, and adventitia. At this
late time, Ki-67 staining was virtually absent, and SMC
marker expression (-actin and smoothelin) had returned
in most of the neointima and media. Notably, the popula-
tion of survivin cells showed little if any overlap with
smoothelin or -actin expression at 35 days after injury.
Survivin expression in atherosclerotic lesions. The un-
injured thoracic aortae of cholesterol-fed rabbits develop
scattered focal fatty streaks characteristic of early athero-
sclerotic plaque. These early lesions demonstrated promi-
nent staining for survivin that was distinct from the under-
lying normal artery wall and adjacent lesion-free areas. (Fig
3, upper row)Within these fatty streaks, survivin colocalized
significantly with the macrophage marker RAM-11, and
some of these cells also expressed Ki-67.
In the cholesterol-fed group, (Fig 3, lower row) balloon
injury of the iliac artery produced robust lesion formation
within 2 weeks, with lesions comprised of SMCs and mac-
rophages in addition to lipid. At 14 days, the developing
neointima expressed -actin and smoothelin, whereas sur-
vivin was localized primarily to the media and adventitia,
overlapping to a varying degree with -actin and RAM-11.
There was virtually no overlap of survivin with smoothelin-
expressing cells at any time point examined.
Survivin expression in experimental vein grafts. Sur-
vivin expression was strongly up-regulated throughout the
wall of vein grafts 7 days after implantation (Fig 4). There
was significant overlap with Ki-67 and -actin at this early
time, notably within the adventitia. Smoothelin staining
was virtually absent in the 1-week graft. By 14 days (not
shown), survivin cells acquired a more organized distribu-
tion pattern in the deeper neointima and adventitia that
persisted in time. At 14 and 30 days, Ki-67 staining dra-
matically declined, and there was a progressive increase in
mature SMC markers (-actin, smoothelin, and desmin)
within the neointima. At late times (30 through 51 days),
persistent, localized areas of survivin staining were noted,
with a decreasing survivin expression gradient from the
, exte
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rectly opposed to that of mature SMC markers such as
smoothelin, which were now localized to the neointima.
Survivin transcription temporally up-regulated in
injured arteries and arterialized vein grafts. Using
RT-PCR, survivin transcripts were detectable in uninjured
rabbit arteries and veins (Fig 5). As expected, testicular
tissue revealed consistent levels of survivin transcripts and
was used as the positive control for quantitative analyses.
Fig 2. Localization of survivin expression in developi
survivin (SVV), -actin, smoothelin (Sm), and Ki-67
explanted at 1 week (top row) and 5 weeks (bottom row). T
1week after balloon injury. At 5 weeks, survivin staining is
overlap with markers of smooth muscle cell differentia
survivin cells. Arrow, internal elastic lamina; arrowhead
Fig 3. Survivin expression in atherosclerotic rabbit arter
(TA) (100) (top row) and injured iliac vessels (4
cholesterol-fed rabbits were stained for survivin (SVV), 
expression is limited to the developing plaque, and co
arteries, survivin is expressed in deeper layers of the vesse
with -actin cells. There is virtually no overlap with sm
lamina; arrowhead, external elastic lamina.The nature of the survivin PCR product was evaluated inseveral ways. Both gel electrophoresis and melt-curve anal-
ysis of real-time PCR products confirmed a single amplified
product in all cases. In addition, this 139 bp product was
fully sequenced, demonstrating 97% nucleotide homology
to the known human survivin sequence.
The survivin/-actin ratio of normal veins did not differ
from that of uninjured arteries. There was also no discernible
difference in survivin transcription between uninjured veins
and very early (16-hour) vein grafts. Survivin up-regulation
terial lesions after balloon injury. Immunostaining for
erformed on serial cryosections (100) from arteries
is overlapping expression of survivin , KI-67 and -actin
ed to the deep intimal and adventitial layers withminimal
r proliferation, suggesting a unique phenotype of the
rnal elastic lamina.
epresentative serial sections of uninjured thoracic aortae
ottom row), 2 weeks after balloon injury (BI) from
, smoothelin (Sm), Ki-67, and RAM-11. In TA, survivin
zes with the macrophage marker RAM-11. In injured
colocalizes with a population of macrophages as well as
elin expression in these lesions. Arrow, internal elasticng ar
was p
here
limit
tion oies. R
0) (b
-actin
locali
l and
oothtrended upward in 1-week grafts, and both 2-week and
scle c
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expression compared with the uninjured veins and uninjured
arteries (P  .02 and P  .01, respectively). At 7 weeks,
survivin transcription was approximately 10-fold higher than
starting levels in ungrafted veins (Fig 5).
The survivin/-actin ratio of uninjured iliac arteries
was not measurably affected by the cholesterol diet. Me-
chanical injury induced survivin expression in all tested
arteries. In the cholesterol-fed group, survivin transcription
after the balloon injury was significantly increased at 3 days,
2 weeks, and 6 weeks vs uninjured controls and chow-fed
animals at 6 weeks (P  .001). The 2-week and 6-week
time points did not differ significantly. Similar findings
were obtained in animals fed normal chow, with marked
up-regulation of survivin expression in balloon-injured ar-
teries at 6 weeks vs uninjured controls (P  .001).
Adenoviral mediated transfer of a dominant negative
survivin construct attenuates intimal hyperplasia after bal-
loon injury. At 4 days after balloon injury, the iliofemoral
arteries demonstrated high rates of both proliferation
(Ki-67 index: T34A, 48% 8% vs GFP, 38% 6%; PNS)
and apoptosis (TUNEL positive T34A, 25%  4% vs GFP,
30%  5%; P  NS) within the vessel wall, consistent with
prior studies20-23 and not demonstrably different between
treatment groups at the single time point examined.
Morphometric evaluation of vessels harvested at 28
days after balloon injury revealed a significant effect of
treatment assignment on neointimal area (mean  SD
mm2: 0.29  0.03 T34A, 0.37 0.06 GFP, 0.42  0.03
saline; P  .0064). Treatment with T34A adenovirus was
associated with a 24% reduction in neointimal area com-
pared with the control vector (P  .019 vs GFP, paired t
test). A significant overall treatment effect was also evident
in I/M area ratio (P  .0029), with a similar though
nonsignificant trend of reduction in the T34A group (20%
vs GFP, P  0.14, paired t test). Overall vessel size or
Fig 4. Localization of survivin expression in experimen
from rabbit vein grafts harvested at 7 and 30 days. Top row
significantly with Ki-67 and -actin; smoothelin (Sm) i
survivin cells demonstrate a more organized distributio
largely negative for Ki-67 and all markers of smooth muluminal area did not differ among the treatment groups.Survivin is expressed in human atherosclerotic plaque
and stenotic vein grafts. Mimicking the pattern observed
in our rabbit vein graft experimental model, survivin ex-
pression was detected by IHC in all human vein grafts
analyzed, with a preferential band-like distribution along
the deeper neointima and around the IEL, and persisting
up to 1,330 days after bypass scattered along the neointima
and adventitia. Normal human radial artery and saphenous
vein controls showed rare isolated cells expressing survivin
(not shown). Carotid plaque specimens likewise demon-
strated significant staining for survivin, localized to the
deeper layers of these complex lesions (Fig 6). As previously
described, expression of mature SMC markers was present
in the media and the neointima with no significant co-
localization observed with survivin.
DISCUSSION
The current studies provide strong supporting evidence
for an important role for survivin, a dual regulator of cell
proliferation and cell death, in the generalized response to
vascular injury. The identification of survivin up-regulation
in diverse forms of vascular injury across species, including
early atherosclerosis, angioplasty-induced neointima, and
vein graft adaptation, suggest that survivin is of fundamen-
tal importance to the cellular events that determine neoin-
tima formation and vascular remodeling. The temporal
pattern of survivin expression after injury is also consistent
with an important role in the early development of intimal
hyperplasia. Furthermore, inhibition of intimal thickening
after the delivery of a dominant-negative survivin construct
provides relevance for survivin as a potential target of
molecular therapies.
The origin, phenotype, and subsequent fate of sur-
vivin cells in the vessel wall remain largely undefined.
Survivin expression at all times appears exclusive of amarker
of mature, contractile SMCs (smoothelin). At the earliest
ein bypass grafts. Representative serial sections (200)
week, survivin (SVV) is strongly expressed, and overlaps
ually absent at this early time. Bottom row, At 30 days,
he deep neointima and adventitial border zones, and are
ell differentiation. Arrowhead, External elastic lamina.tal v
,At 1
s virt
n in ttimes after injury, survivin areas clearly overlap with pro-
plate
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pression. This is noteworthy in the adventitia of vein grafts,
where the -actin population has been postulated to
represent transformation of adventitial “myofibroblasts”
into cells that acquire SMC lineage markers as they migrate
into the vessel wall.
At late times after injury, survivin cells persist in
deeper layers of the neointima and outer vessel wall, where
they appear to be largely negative for both -actin and
smoothelin expression. This unique phenotype leads us to
speculate on a potential role for survivin in the maintenance
of a dedifferentiated neointimal precursor cell that is in-
volved in the processes of vascular repair. In cholesterol-fed
animals, survivin expression was also markedly increased in
arterial lesions and in this case, also colocalizes in part with
RAM-11macrophages.
Recent studies have suggested diverse origins for the
cells that populate the injured vessel wall and ultimately
contribute to neointimal lesion formation. Activation and
dedifferentiation of resident medial SMC, transformation
of adventitial myofibroblasts,24 and recruitment of circulat-
ing precursor cells with subsequent differentiation into an
SMC lineage25,26 are all mechanisms that have been dem-
Fig 5. Analysis of survivin transcription in vascular injury
(RT-PCR) analysis of cDNA prepared from rabbit ve
survivin/-actin ratio calculated as described. After arter
through 7 weeks (*P  .02 vs uninjured vein; #P  .01
expression significantly increased in the arteries, which
(results are mean  SD). C, Representative gel (2% ag
harvested from Jurkat cells (J), rabbit testicle (T), uninju
rabbits, uninjured rabbit veins (NV), vein grafts (VG),
balloon injury (BI). Water (W) served as a negative temonstrated in animal models. Of further interest, recent datademonstrate an inverse correlation between survivin ex-
pression and hematopoietic cell (CD34) differentia-
tion,27 as well as a potential role for survivin in regulating
the inflammatory response.28 Our present studies did not
allow us to identify the source of survivin cells in devel-
oping lesions, although the histologic pattern suggests that
either or both of the circulatory and adventitial compart-
ments may be involved. Further investigations using alter-
native models will be required to definitively establish the
origin and fate of survivin cells in vascular injury.
An intriguing possibility is that survivin expression is
linked to the regulation of a SMC phenotype after vas-
cular injury. Support for this notion rests on the emerg-
ing developmental role of survivin that continues to be
defined.
12, 29,30
Survivin is known to be widely expressed
during embryonic development but is largely absent in
the nonproliferating cells of the adult organism. Among
normal adult organs, only gonadal tissue,31 thymus,32
and alpha cells of the pancreatic islet33 have been de-
scribed to express survivin. survivin expression is tightly
regulated during development, and it appears to regulate
other critical developmental genes at the transcriptional
level. A specific role for survivin in vasculogenesis and
antitative reverse transcriptase-polymerase chain reaction
afts (A) and injured arteries (B) was performed, and
tion, survivin expression in vein grafts rose from 1 week
injured artery). Beginning at 3 days postinjury, survivin
ued through 6 weeks (P  .001 vs uninjured arteries)
electropheresis of RT-PCR products. Total RNA was
rteries from normal chow (NC) or cholesterol-fed (CF)
rteries from NC or CF rabbits at indicated times after
control.. Qu
in gr
ializa
vs un
contin
arose)
red a
and aSMC differentiation has not yet been described.
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formed in a small subgroup of animals to extend the proof-
of-concept from prior studies in the mouse18 to a more
clinically relevant angioplasty model. In addition to the
small sample size, interpretation of these data are limited by
the use of a nonrandomized, nonblinded design. The lack
of a measurable effect of T34A on proliferation or apoptosis
at 4 days may be related to the finding that endogenous
survivin expression appears to peak somewhat later (1
week), and may not be ideally matched spatially or tempo-
rally to the mode of gene delivery used in this model.
Nonetheless, a significant reduction in neointimal mass was
observed, confirming the validity of survivin as a therapeu-
tic target for further study.
In conclusion, these studies provide further evidence
that the inhibitor of apoptosis protein, survivin, known to
be an important modulator of neoplastic disease, has a
significant role in the development of vascular lesions in
diverse settings. Ongoing investigations seek to better
identify the nature of survivin-expressing cells, their contri-
bution to lesion development, and the molecular-signaling
pathways by which survivin may influence a SMC pheno-
type. However, based on the observations reported thus
far, we suggest that survivin may be a relevant target for
therapeutic manipulation in vascular injury.
Human carotid plaque specimens kindly provided by
Peter Libby and Fred J. Schoen through the cardiovascular
tissue bank at Brigham and Women’s Hospital (HL-PO-1
48743).
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